Overview

The goal of this study is to learn if a suprachoroidal triamcinolone injection can treat vision-threatening swelling in the center of the retina (macular edema) caused by non-infectious uveitis, especially in people who did not improve after a standard steroid injection around the eye (sub-Tenon injection).

The main questions it aims to answer are:

Does vision improve on the eye chart after the injection?

Does the injection lower retinal swelling (reduction in thickness) within 3 months?

Participants will:

Have a pre-treatment check (vision test, slit-lamp exam, and a retinal scan called OCT).

Receive one suprachoroidal triamcinolone injection under anesthetics drops in a sterile setting (operating room) with standard monitoring.

Return for visits about 1 month and 3 months after treatment for repeat vision tests, and OCT scans.

Contact the clinic if they notice pain, redness, new floaters, or worsening vision.

Eligibility

Inclusion Criteria:

• Non-infectious uveitis complicated with macular edema
• Uveitic macular edema of less than four months' duration
• Macular edema persisted despite lack of intra-ocular inflammation
• No response to posterior sub-Tenon triamcinolone acetonide injections

Exclusion Criteria:

• Those with epiretinal membrane-associated macular edema
• Below 18 years